RxDoctor Payments Data

Natalia Hernandez, MD

Clinical Cardiac Electrophysiology · Pensacola, FLNPI 1528385325

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (56.3%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Medtronic at 45.7% of the total. Reporting peaked in 2019 at $5,189 and has fallen 71.7% since, to $1,469 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in FL, where the typical reported total is $25,729.

$7,755in general payments, 2019–2025

Across 80 payments — averaging $96.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Boston Scientific$1K
  • Medical Device Business Services, Inc.$1K
  • Biosense Webster, Inc.$342
  • Bluewind Medical$202
  • AbbVie$183
  • plus $878 from 14 others

What the payments were for

  • Grants$391%
  • Travel & lodging$4,37056%
  • Food & beverage$2,96438%
  • Education$3825%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,755 in reported general payments places this provider in the 15th percentile of 249 clinical cardiac electrophysiology providers in Florida.

See all clinical cardiac electrophysiology providers in Florida →

Medicare billing

Part B allowed, 2024
$430,473
Medicare patients
1,359
Services billed
5,503

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban361$407,678
XareltoRivaroxaban86$90,209
MultaqDronedarone Hcl27$33,631
Metoprolol Succinate245$5,101
Dofetilide13$4,580
Amiodarone Hcl70$1,206
SotalolSotalol Hcl35$757
Diltiazem 24hr Er (Cd)Diltiazem Hcl34$720
Digoxin19$656
Diltiazem 24hr Er (La)Diltiazem Hcl12$574
Metoprolol Tartrate64$524
Flecainide Acetate15$497
Potassium Chloride18$368
Losartan Potassium22$310
Warfarin Sodium31$238

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$73$407,678361 claims
Johnson & JohnsonXarelto$39$90,20986 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 15th percentile of 249 clinical cardiac electrophysiology providers in Florida.

Other clinical cardiac electrophysiology in Pensacola

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →